MOTCO’s Editas Medicine EDIT Stock Holding History

MOTCO’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-110	Closed	-$375	–	506
2024 Q3	$375	Hold	110	–	–	﹤0.01%	586
2024 Q2	$514	Buy	+110	New	+$621	﹤0.01%	705

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MOTCO's EDIT Position: Q4 2024 in Review

MOTCO sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 110 shares — an estimated $375 sold.

MOTCO first reported a position in EDIT in Q2 2024 and held it in 2 quarters. The position peaked at $514 in Q2 2024. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

MOTCO reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
MOTCO sold 110 Editas Medicine shares in Q4 2024, an estimated $375.
MOTCO first reported a position in Editas Medicine in Q2 2024 and held it in 2 quarters.
MOTCO's Editas Medicine position peaked at $514 in Q2 2024.
206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on MOTCO's 13F filing for Q4 2024, filed 5 Feb 2025.